(Q36259999)

13 August 2017

1 reference

title

Neurocysticercosis: updated concepts about an old disease (English)

1 reference

Cysticercosis Working Group in Peru

13 August 2017

1 reference

series ordinal

3

object named as

Cysticercosis Working Group in Peru

1 reference

13 August 2017

1

Hector H Garcia

1 reference

13 August 2017

Oscar H Del Brutto

2

1 reference

13 August 2017

1 October 2005

1 reference

13 August 2017

1 reference

13 August 2017

4

1 reference

13 August 2017

10

1 reference

13 August 2017

653-661

1 reference

Taenia solium cysticercosis

13 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970194-0

7 January 2021

New concepts in the diagnosis and management of neurocysticercosis (Taenia solium).

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970194-0

7 January 2021

Neurocysticercosis in radiographically imaged seizure patients in U.S. emergency departments

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970194-0

7 January 2021

Neurocysticercosis in an Orthodox Jewish community in New York City

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970194-0

7 January 2021

Diagnosis, treatment and control of Taenia solium cysticercosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970194-0

7 January 2021

Taenia solium cysticercosis in young pigs: age at first infection and histological characteristics.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970194-0

7 January 2021

Control of Taenia solium

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970194-0

7 January 2021

Neurocysticercosos in South-Central America and the Indian subcontinent. A comparative evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970194-0

7 January 2021

Epilepsy and neurocysticercosis in an Andean community.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970194-0

7 January 2021

A population-based, case-control study of Taenia solium taeniasis and cysticercosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970194-0

7 January 2021

An epidemiological study of epilepsy and epileptic seizures in two rural Guatemalan communities

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970194-0

7 January 2021

Epilepsy and neurocysticercosis in Atahualpa: a door-to-door survey in rural coastal Ecuador.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970194-0

7 January 2021

Prevalence, incidence, and etiology of epilepsies in rural Honduras: the Salamá Study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970194-0

7 January 2021

Neurocysticercosis: an update

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970194-0

7 January 2021

Epilepsy due to neurocysticercosis: analysis of 203 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970194-0

7 January 2021

Mechanisms of hydrocephalus in cerebral cysticercosis: implications for therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970194-0

7 January 2021

Cysticercotic encephalitis: a severe form in young females

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970194-0

7 January 2021

Cysticercosis and cerebrovascular disease: a review

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970194-0

7 January 2021

Imaging findings in neurocysticercosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970194-0

7 January 2021

Immunodiagnosis of neurocysticercosis. Disappointing performance of serology (enzyme-linked immunosorbent assay) in an unbiased sample of neurological patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970194-0

7 January 2021

Taenia solium metacestode glycoproteins as diagnostic antigens for solitary cysticercus granuloma in Indian patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970194-0

7 January 2021

Circulating parasite antigen in patients with hydrocephalus secondary to neurocysticercosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970194-0

7 January 2021

Proposed diagnostic criteria for neurocysticercosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970194-0

7 January 2021

Current consensus guidelines for treatment of neurocysticercosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970194-0

7 January 2021

Comparison of therapeutic regimen of anticysticercal drugs for parenchymal brain cysticercosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970194-0

7 January 2021

Medical treatment of cysticercosis--effective.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970194-0

7 January 2021

High-dose praziquantel for neurocysticercosis: efficacy and tolerability

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970194-0

7 January 2021

Single-day praziquantel therapy for neurocysticercosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970194-0

7 January 2021

Plasma levels of praziquantel decrease when dexamethasone is given simultaneously.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970194-0

7 January 2021

Short course of albendazole therapy for neurocysticercosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970194-0

7 January 2021

Albendazole therapy for neurocysticercosis: a prospective double-blind trial comparing 7 versus 14 days of treatment. Cysticercosis Working Group in Peru.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970194-0

7 January 2021

Medical treatment of cysticercosis--ineffective

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970194-0

7 January 2021

Is the course of neurocysticercosis modified by treatment with antihelminthic agents?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970194-0

7 January 2021

Medical treatment for neurocysticercosis characterized by giant subarachnoid cysts

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970194-0

7 January 2021

A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970194-0

7 January 2021

Calcific neurocysticercosis and epileptogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970194-0

7 January 2021

Prognostic factors for seizure recurrence after withdrawal of antiepileptic drugs in patients with neurocysticercosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970194-0

7 January 2021

Prognosis for seizure recurrence in patients with newly diagnosed neurocysticercosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970194-0

7 January 2021

Therapy for neurocysticercosis: a reappraisal.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970194-0

7 January 2021

Hydrocephalus secondary to cysticercotic arachnoiditis. A long-term follow-up review of 92 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970194-0

7 January 2021

Effects of prednisone on ventriculoperitoneal shunt function in hydrocephalus secondary to cysticercosis: a preliminary study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970194-0

7 January 2021

Disappearing CT lesions in Indian patients with epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970194-0

7 January 2021

Single small enhancing CT lesions in Indian patients with epilepsy: clinical, radiological and pathological considerations

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970194-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970194-0

1 reference

7 January 2021

Validation of diagnostic criteria for solitary cerebral cysticercus granuloma in patients presenting with seizures.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970194-0

7 January 2021

Differential diagnosis between cerebral tuberculosis and neurocysticercosis by magnetic resonance spectroscopy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970194-0

7 January 2021

Edema associated with calcified lesions in neurocysticercosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970194-0

7 January 2021

Calcified cysticerci provoke perilesional edema and seizures.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970194-0

7 January 2021

Albendazole in single CT ring lesions in epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970194-0

7 January 2021

Albendazole therapy in children with focal seizures and single small enhancing computerized tomographic lesions: a randomized, placebo-controlled, double blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970194-0

7 January 2021

Efficacy of albendazole and short-course dexamethasone treatment in children with 1 or 2 ring-enhancing lesions of neurocysticercosis: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970194-0

7 January 2021

Neurocysticercosis in children: clinical findings and response to albendazole therapy in a randomized, double-blind, placebo-controlled trial in newly diagnosed cases

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970194-0

7 January 2021

Corticosteroids versus albendazole for treatment of single small enhancing computed tomographic lesions in children with neurocysticercosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970194-0

7 January 2021

Cysticercosis mimicking brain tumor: the role of albendazole as a diagnostic tool

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970194-0

7 January 2021

Seizure outcome in patients with a solitary cerebral cysticercus granuloma

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970194-0

7 January 2021

Hydrocephalus in cerebral cysticercosis. Pathogenic and therapeutic considerations.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970194-0

7 January 2021

The racemose form of cerebral cysticercosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970194-0

7 January 2021

Frequency of cerebral arteritis in subarachnoid cysticercosis: an angiographic study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970194-0

7 January 2021

Neurocysticercosis: focus on intraventricular disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970194-0

7 January 2021

Neurocysticercosis: A Neurosurgical Perspective

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970194-0

7 January 2021

Endoscopic management of supratentorial ventricular neurocysticercosis: case series and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970194-0

7 January 2021

Endoscopic management of cysticercal cysts within the lateral and third ventricles

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970194-0

7 January 2021

Intrasellar cysticercosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970194-0

7 January 2021

Spinal intramedullary cysticercosis in a five-year-old child: case report and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970194-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970194-0

1 reference

7 January 2021

Intramedullary cervical spine cysticercosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970194-0

7 January 2021

Visual loss in cysticercosis: analysis of 23 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970194-0

7 January 2021

Ocular and orbital cysticercosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970194-0

7 January 2021

Pseudohypertrophic myopathy in cysticerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970194-0

7 January 2021

Cysticercosis and epilepsy: a critical review.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970194-0

7 January 2021

Relationship Between Epilepsy and Tropical Diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970194-0

7 January 2021

Neurocysticercosis: a major cause of neurological disease worldwide

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970194-0

7 January 2021

Neurocysticercosis: association between seizures, serology, and brain CT in rural Peru

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970194-0

7 January 2021

Mass treatment against human taeniasis for the control of cysticercosis: a population-based intervention study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970194-0

7 January 2021

Mass chemotherapy for intestinal Taenia solium infection: effect on prevalence in humans and pigs

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970194-0

7 January 2021

Epidemiologic study and control of Taenia solium infections with praziquantel in a rural village of Mexico

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970194-0

7 January 2021

10.1016/S1474-4422(05)70194-0

Identifiers

DOI

1 reference

13 August 2017

1 reference

PubMed ID

16168934